{"title":"在ad高危人群中,血脑屏障通透性因脑区域和APOE4状态而异,并与大脑微观结构相关","authors":"Seraphina K. Solders , Qian Shen , Emilie T. Reas","doi":"10.1016/j.nicl.2025.103805","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Although strong evidence exists for blood–brain barrier (BBB) disruption in Alzheimer’s disease (AD), substantial uncertainty remains regarding its role. We address gaps and inconsistencies in the literature by examining regional variation in BBB permeability among cognitively normal older adults enriched for AD risk, the influence of genetic risk and its interactions with amyloid-β and sex, and the relationships between BBB breakdown and brain microstructure. Additionally, we compare two methods of quantifying BBB permeability.</div></div><div><h3>Methods</h3><div>Dynamic contrast-enhanced magnetic resonance imaging and restriction spectrum imaging were performed on 48 cognitively normal older adults. We examined differences in whole-brain regional BBB permeability between <em>APOE4</em> carriers and non-carriers, as well as associations with brain microstructure. Analyses tested interactions of <em>APOE4</em> with sex and amyloid-β positivity, and were compared using continuous measurements of permeability (K<sub>trans</sub>) and an abnormal leakage index (ALI).</div></div><div><h3>Results</h3><div>BBB permeability was variable, with highest values in cortical gray matter, including inferior frontal, temporal, and some sensory regions across the full sample. <em>APOE4</em> carriers had elevated permeability throughout superior occipital, parietal, and frontal cortical regions compared to non-carriers. Results were unchanged after controlling for amyloid-β positivity or when using ALI instead of K<sub>trans</sub>. Higher permeability correlated with altered microstructural patterns, with the most robust relationships among <em>APOE4</em> carriers, amyloid-β positive individuals, and women.</div></div><div><h3>Discussion</h3><div>Individuals at greater genetic risk for AD demonstrate elevated cortical BBB permeability associated with microstructural abnormalities. These relationships were seen in a widespread spatial pattern that is dissimilar from the stereotypical spread of AD neuropathology.</div></div>","PeriodicalId":54359,"journal":{"name":"Neuroimage-Clinical","volume":"46 ","pages":"Article 103805"},"PeriodicalIF":3.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Blood-brain barrier permeability varies by brain region and APOE4 status and correlates with brain microstructure among high-AD risk groups\",\"authors\":\"Seraphina K. Solders , Qian Shen , Emilie T. Reas\",\"doi\":\"10.1016/j.nicl.2025.103805\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Although strong evidence exists for blood–brain barrier (BBB) disruption in Alzheimer’s disease (AD), substantial uncertainty remains regarding its role. We address gaps and inconsistencies in the literature by examining regional variation in BBB permeability among cognitively normal older adults enriched for AD risk, the influence of genetic risk and its interactions with amyloid-β and sex, and the relationships between BBB breakdown and brain microstructure. Additionally, we compare two methods of quantifying BBB permeability.</div></div><div><h3>Methods</h3><div>Dynamic contrast-enhanced magnetic resonance imaging and restriction spectrum imaging were performed on 48 cognitively normal older adults. We examined differences in whole-brain regional BBB permeability between <em>APOE4</em> carriers and non-carriers, as well as associations with brain microstructure. Analyses tested interactions of <em>APOE4</em> with sex and amyloid-β positivity, and were compared using continuous measurements of permeability (K<sub>trans</sub>) and an abnormal leakage index (ALI).</div></div><div><h3>Results</h3><div>BBB permeability was variable, with highest values in cortical gray matter, including inferior frontal, temporal, and some sensory regions across the full sample. <em>APOE4</em> carriers had elevated permeability throughout superior occipital, parietal, and frontal cortical regions compared to non-carriers. Results were unchanged after controlling for amyloid-β positivity or when using ALI instead of K<sub>trans</sub>. Higher permeability correlated with altered microstructural patterns, with the most robust relationships among <em>APOE4</em> carriers, amyloid-β positive individuals, and women.</div></div><div><h3>Discussion</h3><div>Individuals at greater genetic risk for AD demonstrate elevated cortical BBB permeability associated with microstructural abnormalities. These relationships were seen in a widespread spatial pattern that is dissimilar from the stereotypical spread of AD neuropathology.</div></div>\",\"PeriodicalId\":54359,\"journal\":{\"name\":\"Neuroimage-Clinical\",\"volume\":\"46 \",\"pages\":\"Article 103805\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroimage-Clinical\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2213158225000750\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROIMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroimage-Clinical","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213158225000750","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROIMAGING","Score":null,"Total":0}
Blood-brain barrier permeability varies by brain region and APOE4 status and correlates with brain microstructure among high-AD risk groups
Background
Although strong evidence exists for blood–brain barrier (BBB) disruption in Alzheimer’s disease (AD), substantial uncertainty remains regarding its role. We address gaps and inconsistencies in the literature by examining regional variation in BBB permeability among cognitively normal older adults enriched for AD risk, the influence of genetic risk and its interactions with amyloid-β and sex, and the relationships between BBB breakdown and brain microstructure. Additionally, we compare two methods of quantifying BBB permeability.
Methods
Dynamic contrast-enhanced magnetic resonance imaging and restriction spectrum imaging were performed on 48 cognitively normal older adults. We examined differences in whole-brain regional BBB permeability between APOE4 carriers and non-carriers, as well as associations with brain microstructure. Analyses tested interactions of APOE4 with sex and amyloid-β positivity, and were compared using continuous measurements of permeability (Ktrans) and an abnormal leakage index (ALI).
Results
BBB permeability was variable, with highest values in cortical gray matter, including inferior frontal, temporal, and some sensory regions across the full sample. APOE4 carriers had elevated permeability throughout superior occipital, parietal, and frontal cortical regions compared to non-carriers. Results were unchanged after controlling for amyloid-β positivity or when using ALI instead of Ktrans. Higher permeability correlated with altered microstructural patterns, with the most robust relationships among APOE4 carriers, amyloid-β positive individuals, and women.
Discussion
Individuals at greater genetic risk for AD demonstrate elevated cortical BBB permeability associated with microstructural abnormalities. These relationships were seen in a widespread spatial pattern that is dissimilar from the stereotypical spread of AD neuropathology.
期刊介绍:
NeuroImage: Clinical, a journal of diseases, disorders and syndromes involving the Nervous System, provides a vehicle for communicating important advances in the study of abnormal structure-function relationships of the human nervous system based on imaging.
The focus of NeuroImage: Clinical is on defining changes to the brain associated with primary neurologic and psychiatric diseases and disorders of the nervous system as well as behavioral syndromes and developmental conditions. The main criterion for judging papers is the extent of scientific advancement in the understanding of the pathophysiologic mechanisms of diseases and disorders, in identification of functional models that link clinical signs and symptoms with brain function and in the creation of image based tools applicable to a broad range of clinical needs including diagnosis, monitoring and tracking of illness, predicting therapeutic response and development of new treatments. Papers dealing with structure and function in animal models will also be considered if they reveal mechanisms that can be readily translated to human conditions.